Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
The serum concentrations of CA 125 and placental alkaline phosphatase were analyzed in 16 patients with ovarian cancer. Increased serum levels of CA 125 and placental alkaline phosphatase were observed in 75% and 50% of the cancer patients, respectively. The serum levels of these tumor markers were not correlated, supporting their distinct antigenic nature. CA 125 seems to be a more promising tumor marker for ovarian cancer than placental alkaline phosphatase.
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood*; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D005260:Female; D058851:GPI-Linked Proteins; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D010920:Placenta / Q000201:enzymology*
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D058851:GPI-Linked Proteins; D007527:Isoenzymes; D000469:Alkaline Phosphatase; C019839:alkaline phosphatase, placental